Activity of crude extract of Rubus crataegifolius roots as a potent apoptosis inducer and DNA topoisomerase I inhibitor

Anti-inflammatory effects of total alkaloids from Rubus alceifolius Poir [corrected]. on non-alcoholic fatty liver disease through regulation of the NF-κB pathway

We aimed to explore the anti-inflammatory effects of total alkaloids inRubus alceifolius Poir [corrected]. (TARAP) on non-alcoholic fatty liver disease, and to investigate the possible molecular mechanisms. A rodent non-alcoholic fatty liver disease (NAFLD) model was established by administration of a modified high-fat diet ad libitum for 8 weeks. Rats were treated with polyene phosphatidylcholine (PP), TARAP low‑dose (0.72 g/kg body weight/day) and TARAP high-dose (1.44 g/kg body weight/day). The model group and the control group received distilled water. After treatment for 4 weeks, the blood samples were obtained from the abdominal aorta, and the levels of serum ALT, AST, GGT, ALP, TG, TC, HDL-C and LDL-C were measured. Changes in liver tissue morphology were evaluated by H&E staining. The expression levels of nuclear factor (NF)-κB, cyclooxygenase-2 (COX‑2), interleukin (IL)-6 and tumor necrosis factor (TNF)-α in rat livers were assayed by reverse transcription‑polymerase chain reaction (RT-PCR) and immunohistochemistry. Both TARAP and PP attenuated hepatic steatosis induced by the high-fat diet. The modified high-fat diet caused a significant increase in ALT, AST, GGT, ALP, TG, TC, LDL-C levels and a decrease in HDL-C levels. TARAP and PP treatment abrogated the increase in the levels of liver enzymes and the levels of TG, TC, LDL-C, as well as suppressed the increase in HDL-C levels. The results of RT-PCR and immunohistochemical assay showed that PP and TARAP treatment decreased the expression of NF-κB, COX-2, IL-6 and TNF-α. In conclusion, these results suggest that TARAP may protect against NAFLD through regulation of the NF-κB pathway.

Rubus - A Review of its Phytochemical and Pharmacological Profile

Species of the genus Rubus (family Rosaceae, sub-family Rosoideae, tribe Potentilleae) are widely distributed in the warmer temperate zones of the northern hemisphere. Rubus species have been known since ancient times for their curative properties, and have been used for the treatment of various ailments, such as wounds, diarrhea, colic pain, diabetes, inflammatory disorders, and as antimicrobial agents. However, their use has been based mainly on empirical findings. This contribution provides a comprehensive review of the work published on the phytochemistry and pharmacology of the Rubus species over the past few years, in order to obtain a better understanding of the biological significance of this large genus.

Therapeutic Potential and Chemical Composition of Plants from the Genus Rubus: A Mini Review of the Last 10 Years

Rubus species (Rosaceae) are appreciated for their fruits and their traditional therapeutic uses. Several experimental investigations indicate important biological effects of these plants, related to the presence of different classes of chemical substances, especially terpenoids and phenolic compounds. This work outlines the main biological properties and chemical constituents of the genus Rubus over the last 10 years, with particular emphasis on the plants that occur in Brazil.